Protara Therapeutics logo
Protara Therapeutics TARA
$ 2.38 3.97%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Protara Therapeutics Financial Ratios 2011-2024 | TARA

Annual Financial Ratios Protara Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.0 -0.6 -1.6 -3.8 -1.1 -2.3 -1.4 -1.1 -7.2 -9.6 - - -

P/S

- - - - - - - - - 10.9 - - -

EPS

-3.6 -5.9 -4.2 -4.7 -3.0 -45.8 -2.1 -1.7 -1.3 -3.2 -59.7 -61.2 -

EV (Enterprise Value)

12.4 M 27.7 M 50.8 M -34.6 M 11.2 M 30.5 M 30.4 M 154 K 118 M -34.3 M -2.79 M -2.41 M -

EBITDA per Share

-3.82 -5.93 -4.22 -4.73 -30.1 -47 -70 -69 -50.6 -98.6 - - -

EV/EBITDA

-0.9 1.1 -0.7 -1.3 -0.7 0.2 -5.5 4.9 - - -

PEG

0.04 0.02 0.05 -0.05 -0.03 -0.07 2.0 0.03 0.38 0.05 - - -

P/B

0.6 0.4 0.5 0.7 2.6 2.3 1.2 0.8 2.4 0.4 - - -

P/CF

-1.1 -1.5 -2.2 -5.4 -1.1 -2.0 -1.9 -1.3 -8.6 -3.2 - - -

ROE %

-59.16 -64.61 -29.18 -17.05 -234.54 -101.40 -86.25 -74.21 -33.72 -4.05 - - -

ROA %

-51.19 -58.22 -27.38 -16.72 -214.94 -88.13 -68.13 -65.55 -31.65 -3.94 - - -

ROCE %

-63.84 -65.69 -29.33 -17.20 -238.64 -104.54 -87.40 -74.67 -32.92 -9.19 - - -

Current Ratio

7.4 10.1 16.2 58.1 12.0 7.5 4.7 8.4 16.1 36.2 - - -

DSO

- - - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Protara Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.5 -0.45 -0.97 - -0.87 -1 -0.8 - -0.68 -0.76 -0.96 - -0.96 -1.14 -1.2 - -1.26 -1.22 -1.81 - -0.92 -0.56 -0.58 -0.27 -0.25 -0.28 -0.34 -0.33 -1.08 -0.33 -0.39 -0.42 -0.43 -0.48 -0.4 -0.38 -0.33 -0.31 -0.28 0.52 -31 -18.55 -18.09 -16.41 -15.6 -13.33 -14.64 - - - - - - - -

EBITDA per Share

- - -1.03 - - - -0.85 - -0.69 -0.76 -0.96 - -0.96 -1.13 -1.21 - -1.26 -1.24 -1.82 - -0.88 -0.55 -0.52 - -0.26 -0.28 -0.36 - -0.69 -0.34 -0.39 - -0.43 -0.47 -0.41 - -0.31 -0.3 -0.28 - 0.64 -10.4 -8.02 - -7.9 - - - - - - - - - -

ROE %

-55.86 -54.96 -57.87 -35.61 -41.13 -33.85 -26.47 -18.46 -24.79 -25.58 -26.88 -20.65 -24.65 -22.32 -18.74 -12.63 97.99 212.62 283.34 249.57 227.51 94.82 3.82 -75.67 -111.10 -124.47 -116.74 -70.28 -88.39 -71.45 -75.87 -74.21 -66.10 -56.10 -43.54 -33.72 -14.94 -12.73 -7.84 -4.05 -10.44 -2.06 1.04 4.48 2.09 - - - - - - - - - -

ROA %

-48.71 -47.93 -50.45 -31.52 -36.69 -30.72 -24.37 -17.36 -23.32 -24.11 -25.36 -19.73 -23.65 -21.61 -18.36 -12.39 -204.95 -393.60 -506.95 -434.43 -453.60 -280.21 -184.09 -65.77 -93.75 -102.56 -94.57 -55.51 -71.51 -59.85 -65.27 -65.55 -58.94 -50.58 -39.93 -31.65 -13.73 -11.87 -7.38 -3.94 -54.83 -85.88 -82.86 -79.52 -37.16 - - - - - - - - - -

ROCE %

-60.85 -59.68 -62.34 -38.42 -44.15 -35.97 -27.71 -18.86 -25.21 -25.84 -27.02 -20.74 -24.79 -22.48 -18.96 -12.79 97.83 212.51 283.29 249.57 226.96 93.73 2.13 -78.20 -113.63 -126.44 -119.22 -71.31 -89.95 -73.17 -76.37 -56.81 -64.83 -54.20 -41.63 -23.16 -22.99 -14.82 -10.00 -5.22 -3.32 -1.58 1.46 1.90 1.90 - - - - - - - - - -

Current Ratio

7.7 10.6 7.0 7.4 7.7 9.6 9.1 10.1 15.8 16.4 17.9 16.2 17.6 18.0 44.9 51.9 51.9 51.9 51.9 0.4 0.4 0.4 0.4 7.6 7.6 7.6 7.6 4.8 4.8 4.8 4.8 8.6 8.6 8.6 8.6 16.3 16.3 16.3 16.3 36.3 36.3 36.3 36.3 0.6 0.6 - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency